Copy of Preventing Cardiovascular Diseases

Preventing Cardiovascular Diseases

Your Heart Attack Is 20 Years in the Making

Cardiovascular disease kills around 160,000 people in the UK every year — roughly one every three minutes. Most of those deaths follow a process that began not in old age but in middle life, or earlier. Atherosclerosis — the gradual hardening and narrowing of arteries caused by plaque accumulation — is well underway in many people by their 40s. It produces no symptoms. It doesn't show up in a standard health check. And by the time it announces itself — as a heart attack, a stroke, or chest pain on exertion — the disease is typically well-established. The clinical event is rarely the beginning of the story. It is closer to the end of a very long chapter.

This matters because it reframes the question. Cardiovascular prevention isn't about reacting to a diagnosis. It's about understanding a slow biological process and interrupting it at the right points — ideally long before any damage becomes irreversible. The good news is that the process is interruptible, that the interventions are well understood, and that people who take them seriously in midlife see measurable, significant reductions in risk. The less good news is that the standard picture most people have of cardiovascular risk — high cholesterol, high blood pressure, family history — is incomplete in ways that matter.

Atherosclerosis: A 40-Year Process

How cardiovascular disease develops — and where the key intervention windows are

20s–30s

Early endothelial damage

Smoking, poor diet, elevated blood pressure, and insulin resistance begin injuring the vessel lining. Fatty streaks form. No symptoms. Often no awareness.

✓ Intervention: Stop smoking · Improve diet · Check blood pressure

40s–50s

Plaque development

Foam cells accumulate into fibrous plaques. Arteries begin to narrow. Still asymptomatic in most cases. This is when coronary artery calcium scoring provides the most actionable information.

✓ Intervention: ApoB · Lp(a) · CAC score · Statin if indicated · Exercise

50s–60s

Significant narrowing & vulnerable plaques

Plaques with thin caps and large lipid cores become vulnerable to rupture. Some people begin experiencing exertional symptoms. Risk of cardiac event escalates significantly.

✓ Intervention: Stress test · Aggressive BP & lipid management · Cardiology review

60s–70s+

Plaque rupture / clinical event

Plaque rupture triggers clot formation. Heart attack or stroke. This is the moment most people associate with heart disease — but it is the end of a 30–40 year process, not the beginning.

Emergency treatment · Secondary prevention · Lifestyle overhaul

160,000

CVD deaths per year in the UK — one every 3 minutes

1 in 5

people have elevated Lp(a) — a genetic risk factor not in standard panels

10–15mmHg

blood pressure reduction achievable through lifestyle alone — equivalent to a first-line drug

Timeline is illustrative. Progression varies significantly by individual risk factor burden. Intervention at any stage produces benefit — but earlier intervention produces more.

How atherosclerosis actually develops

The process begins with damage to the endothelium — the thin layer of cells lining the inside of blood vessel walls. Smoking, chronically elevated blood pressure, high glucose, oxidised LDL particles, and inflammation all injure the endothelium. Once the lining is compromised, LDL particles — particularly the small, dense variety — penetrate the vessel wall and become oxidised. The immune system responds by sending macrophages to engulf them. These macrophages become engorged with lipid and turn into what pathologists call foam cells, which accumulate to form fatty streaks. Over years, these streaks develop into plaques — fibrous, calcified structures that narrow the artery and restrict blood flow.

The most dangerous moment is not necessarily the most narrowed artery. It is the rupture of a vulnerable plaque — a plaque with a thin fibrous cap and a large lipid core. When such a plaque ruptures, the body responds as it would to any wound: by forming a clot. In an artery, that clot can be catastrophic. If it blocks the coronary artery feeding the heart muscle, the result is a heart attack. If it blocks an artery supplying the brain, the result is a stroke. The heart attack itself takes minutes. The plaque that caused it took decades.

The cholesterol conversation — what most people are getting wrong

The standard NHS lipid panel reports total cholesterol, HDL, LDL, and triglycerides. This is useful but incomplete. As covered in the screenings page, ApoB — the protein that coats every LDL, VLDL, and IDL particle — is a more direct measure of cardiovascular risk than LDL cholesterol concentration. Two people can have identical LDL readings but very different particle counts. More particles mean more opportunities for penetration of the arterial wall. Large studies including INTERHEART have consistently found ApoB to be more predictive of cardiovascular events than LDL-C.

The other piece most people miss is Lp(a) — lipoprotein(a), a genetically determined variant of LDL that is particularly prone to arterial wall penetration and clot promotion. Elevated Lp(a) affects roughly one in five people and is associated with significantly higher cardiovascular risk that is largely independent of other factors. It doesn't respond meaningfully to diet or exercise. It is not measured in standard NHS panels. And because it's genetic, knowing your level is especially important if you have a family history of early heart disease. It needs to be tested once — it doesn't change — and the result should inform how aggressively you manage everything else.

Blood pressure: the silent damage accumulator

Hypertension is responsible for more cardiovascular deaths than any other single modifiable risk factor. It causes damage through sheer mechanical force — the repeated stress of elevated pressure on vessel walls promotes endothelial injury, accelerates atherosclerosis, and over time causes the heart muscle to thicken and stiffen. What makes it particularly dangerous is that it is entirely asymptomatic until it isn't. People can carry blood pressure of 150/95 for years with no awareness. The target for most adults is below 130/80 — a threshold that has been revised downward as the evidence on harm at higher levels has strengthened.

Lifestyle interventions for blood pressure are more effective than most people realise. A sustained reduction in sodium intake, regular aerobic exercise, weight loss in those who are overweight, and the DASH dietary pattern (high in fruit, vegetables, low-fat dairy, and low in saturated fat) can collectively reduce systolic blood pressure by 10–15 mmHg — equivalent to the effect of a first-line antihypertensive drug. For many people in the borderline-high range, this is enough to avoid medication entirely. For those already on medication, it can mean fewer drugs at lower doses.

What exercise actually does to cardiovascular risk

Exercise reduces cardiovascular risk through multiple simultaneous mechanisms, not one. It lowers resting blood pressure and resting heart rate, reduces circulating triglycerides and raises HDL, improves insulin sensitivity, reduces systemic inflammation, promotes collateral blood vessel development in the heart muscle, and improves endothelial function directly. Aerobic exercise in particular stimulates the production of nitric oxide in the endothelium, which relaxes blood vessels, reduces the adhesion of inflammatory cells to vessel walls, and promotes repair. This is not a vague effect. It is a specific, measurable biological response that begins within weeks of starting regular training.

The dose matters. The cardiovascular benefit of exercise follows a broadly dose-dependent curve, with the largest gains occurring when moving from sedentary to lightly active. But the curve continues upward into moderate and vigorous activity. Zone 2 training — steady aerobic work at an intensity where you can hold a conversation but wouldn't choose to — is particularly efficient for cardiovascular adaptation. Two to four hours per week of Zone 2, combined with one to two sessions of higher-intensity work, represents the approach most consistently associated with strong cardiovascular outcomes in the research literature.

'Cardiovascular disease doesn't arrive without warning — it arrives without symptoms. Those are very different things, and understanding the distinction changes what you do about it.'

Statins, aspirin, and the medication conversation

For people with established cardiovascular disease or very high risk, statins are among the most well-evidenced drugs in medicine. Large meta-analyses involving hundreds of thousands of patients show consistent reductions in cardiovascular events, strokes, and all-cause mortality. The controversy around statins — much amplified online — is largely overstated. Muscle side effects occur in a minority of patients, are usually mild, and often resolve with a dose change or switch to a different statin. The benefit-to-risk ratio for people with elevated cardiovascular risk is well established.

For primary prevention — people without established disease — the picture is more nuanced. Statins reduce cardiovascular events in high-risk primary prevention populations, but the absolute risk reduction for any individual is smaller than in secondary prevention. The decision should be made in conversation with a clinician who can quantify your actual risk level, not on the basis of a cholesterol number in isolation. Coronary artery calcium scoring, Lp(a), ApoB, and a family history assessment all contribute to a more accurate risk picture than standard panels alone.

Daily low-dose aspirin for primary prevention is no longer recommended for most people under current guidelines. Three large trials published between 2018 and 2019 found that the bleeding risk largely offsets the cardiovascular benefit in people without established disease. It remains appropriate for secondary prevention. If you're currently taking it on the basis of older advice, it's worth discussing the current evidence with your GP.

The practical bottom line

Cardiovascular risk is not a binary. It's a trajectory — and trajectories can be changed. Know your ApoB and Lp(a), not just your LDL. Know your blood pressure, and if it's above 130/80, take it seriously. Exercise consistently, with enough aerobic work to genuinely stress the cardiovascular system. Don't smoke. If you have a family history of early heart disease, get a coronary artery calcium score before symptoms develop. And if medication is indicated, take it — the evidence base for statins in appropriate populations is among the strongest in preventive medicine.

The window between now and a cardiovascular event is wide for most people reading this. What happens in that window is largely a function of what you know and what you do with it.